CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans-Reference-Cited by-同舟云学术

CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans

Published:2011-05-10 Issue:12 Volume:17 Page:4101-4109
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Huang Rong Rong,Jalil Jason,Economou James S.,Chmielowski Bartosz,Koya Richard C.,Mok Stephen,Sazegar Hooman,Seja Elizabeth,Villanueva Arturo,Gomez-Navarro Jesus,Glaspy John A.,Cochran Alistair J.,Ribas Antoni

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial;European Journal of Cancer;2024-11

2. First-Line Dual Immunotherapy, a Treatment Option in First-Line Metastatic Non–Small-Cell Lung Cancer: Are We Ready to Use It?;Journal of Clinical Oncology;2024-02-01

3. Exploring the safety profile of tremelimumab: an analysis of the FDA adverse event reporting system;International Journal of Clinical Pharmacy;2024-01-20

4. Locally advanced endometrial cancer with multiple immune-related adverse events coinciding with the complete response to radiotherapy after immune checkpoint inhibitor therapy: A case report;Gynecologic Oncology Reports;2023-10

5. Turning up the heat: CTLA4 blockade in urothelial cancer;Nature Reviews Urology;2023-08-22